Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $92.7752W HIGH $137.27
Volume
1.80 M
Value Traded
172.85 M
Short % Float
3.39%
Days to Cover
3.5
+9.51%Week
+13.44%1 Month
+20.83%3 Month
+27.44%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
13.41 B
EPS (TTM)
6.29
P/E Ratio
21.59
Ent. Value
13.30 B
Total Shares
98.65 M
Float Shares
97.65 M
Insiders
1.01%
Institutions
98.23%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
EHC Catalyst Timeline
Dated clinical, regulatory and corporate events for Encompass Health Corporation
Past FDA Catalysts and PDUFA Decisions
How EHC actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
Pipeline Score
Pipeline Value
Valuation Signal
1
Drugs Scored
rNPV / MCap
Top Drug
Top 64%
Mid Cap(rank 431 of 673)
Percentile Rank
| Drug | Indication | Phase | PTRS | rNPV | Status | Enroll | Velocity | Design | Est. Completion | ML Signal | Last Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
| F2 filter and delivery system UnknownCompletedNCT05866640 | Aortic Stenosis | Phase 1 | COMPLETED | 31 | Oct 15, 2024 |
Clinical Trial Results
Readouts, endpoints and source filings for every EHC program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Price Andrew LOfficer (Chief Accounting Officer) | Sell | -5,211 69,483 held | $120.93 | 08/31/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in EHC
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| Avidity Partners | 0.7 % (-30 %) | 4.25 M | 42.00 K |
EHC Institutional Ownership Trends
EHC Short Interest
Shares sold short, counted twice a month.
3.39%
Short % of Float
of tradable shares sold short
3.3M
Shares Sold Short
-5.0% vs prior count
3.5 Moderate
Days to Cover
trading days of normal volume to buy every short share back
941.9K
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How EHC ranks across every disease it competes in
Competitive Position is a premium feature
See how EHC ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialEHC News
-EHC
Oct 28, 2026▲ +7.7%on this news
Encompass Health reports results for third quarter 2026
Encompass Health Corporation reported strong Q3 2026 results, with an 8.9% revenue increase and a 15.5% rise in Adjusted EBITDA. The company opened four new hospitals and added 85 beds to existing facilities. Due to this performance, Encompass Health raised its full-year guidance, reflecting confidence in its growth strategy.
Read more →-EHC
Oct 26, 2026Encompass Health expands in Fort Bend County, Texas, with second small-format hospital in Houston area
Encompass Health Corp. plans to open a new 24-bed inpatient rehabilitation hospital in Richmond, Texas, by 2028. This facility will serve as a satellite location for the Sugar Land hospital, enhancing access to rehabilitation care in the growing Houston area. The hospital will cater to patients recovering from various major illnesses and injuries.
Read more →-EHC
Oct 22, 2026Encompass Health Rehabilitation Hospital of Westover Hills now open in Texas
Encompass Health has opened its 50-bed Rehabilitation Hospital of Westover Hills in San Antonio, Texas. This facility provides essential rehabilitation services for patients recovering from various conditions, including strokes and spinal injuries. With a focus on individualized therapy, the hospital aims to enhance patient independence and quality of life.
Read more →-EHC
Oct 22, 2026Encompass Health declares dividend on common stock
Encompass Health Corp. announced a quarterly cash dividend of $0.21 per share, payable on January 15, 2027. Shareholders of record on January 4, 2027, will receive this dividend. The company is noted for its leadership in inpatient rehabilitation and has received multiple accolades for its services.
Read more →-EHC
Oct 19, 2026Newsweek names Encompass Health America's Most Awarded Leader in Inpatient Rehabilitation for seventh consecutive year
Encompass Health has been named America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek for the seventh consecutive year. A record 78 of its hospitals were recognized on the America's Best Physical Rehabilitation Centers 2026 list, more than any other provider. This ranking reflects the company's commitment to high-quality patient care and rehabilitation services.
Read more →-EHC
Oct 6, 2026Encompass Health Rehabilitation Hospital of Bangor now open in Maine
Encompass Health has opened a new 50-bed rehabilitation hospital in Bangor, Maine, aimed at providing essential rehabilitation services. The facility will assist patients recovering from various serious conditions, offering intensive therapy and personalized care. This opening is expected to improve access to high-quality rehabilitation in the Northeast and relieve pressure on local acute care hospitals.
Read more →-EHC
Oct 1, 2026Encompass Health announces date of 2026 third-quarter earnings call
Encompass Health Corp. has announced its third-quarter earnings call for 2026, scheduled for October 29. The company will report its financial results after the market closes on October 28. Interested parties can join the call via phone or access a live webcast on the company's investor website.
Read more →-EHC
Sep 24, 2026Encompass Health expands in Montgomery County, Texas, with first small-format hospital, replacement hospital
Encompass Health Corp. announced plans to expand its rehabilitation services in Montgomery County, Texas, with a new small-format hospital in Conroe and a replacement hospital in The Woodlands. The Conroe facility will enhance access to specialized care, while the replacement hospital aims to improve patient experience with modern amenities. Both projects reflect the company's commitment to growth and community service.
Read more →-EHC
Sep 15, 2026Encompass Health Rehabilitation Hospital of Lower Providence now open in Pennsylvania
Encompass Health opened a new inpatient rehabilitation hospital in Lower Providence Township, Pennsylvania. The facility has 50 beds and covers more than 54,000 square feet. It is the company's eleventh location in the state. The hospital began accepting patients on September 15, 2026.
Read more →-EHC
Aug 10, 2026Encompass Health prices private offering of additional 5.875% senior notes due 2034
Encompass Health Corp. has announced the pricing of an additional $100 million in 5.875% senior notes due 2034. This offering will be a reopening of previously issued notes and is expected to close on August 13, 2026. The proceeds will be used to repay amounts under the company's senior secured revolving credit facility.
Read more →-EHC
Aug 10, 2026Encompass Health announces launch of private offering of 5.875% senior notes due 2034
Encompass Health Corp. has announced a private offering of $100 million in additional 5.875% senior notes due 2034. This offering aims to refinance existing debt under its senior secured revolving credit facility. The notes will be available to qualified institutional buyers and certain non-U.S. persons, and are not registered under the Securities Act.
Read more →-EHC
Aug 5, 2026▲ +12.6%on this newsshared move
Encompass Health reports results for second quarter 2026
Encompass Health Corporation reported strong second-quarter results for 2026, with a 9.6% increase in net operating revenue and a 9.2% rise in adjusted EBITDA. The company has raised its full-year guidance, anticipating further growth through the opening of additional hospitals. Despite some challenges, including a decrease in adjusted free cash flow, the overall outlook remains optimistic.
Read more →-EHC
Jul 23, 2026Encompass Health increases and declares dividend on common stock
Encompass Health Corp. announced a $0.02 increase in its quarterly dividend, raising it to $0.21 per share. The dividend is payable on October 15, 2026, to shareholders on record as of October 1, 2026. The company is recognized for its leadership in inpatient rehabilitation with a significant national footprint.
Read more →-EHC
Jul 9, 2026Encompass Health announces date of 2026 second quarter earnings call
Encompass Health Corp. has announced its second quarter earnings call for 2026, scheduled for August 6, 2026. The company will report its results after market close on August 5, 2026. Investors can access the call via phone or through a live webcast on the company's investor website.
Read more →-EHC
May 29, 2026Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia
Encompass Health Corp. plans to build a new 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia, relocating from its former 19-bed unit. The new facility will enhance access to rehabilitation services, featuring private rooms and advanced therapy equipment. The hospital aims to serve patients recovering from serious conditions, including strokes and orthopedic issues.
Read more →-EHC
May 14, 2026Encompass Health announces pricing of $500 million of senior notes due 2034 in a private offering
Encompass Health Corp. has announced the pricing of a private offering of $500 million in senior notes due 2034, with a 5.875% interest rate. The company plans to use the proceeds to redeem existing notes and repay part of its revolving credit facility. The offering is expected to close on May 29, 2026, pending customary conditions.
Read more →-EHC
May 14, 2026Encompass Health issues notice for partial redemption of its 4.500% senior notes due 2028
Encompass Health Corp. announced the redemption of $400 million of its 4.500% senior notes due 2028, set for June 13, 2026. The company anticipates a $3.2 million loss on this early debt extinguishment. The total outstanding principal of these notes was $800 million as of May 14, 2026.
Read more →-EHC
May 14, 2026Encompass Health announces private offering of senior notes
Encompass Health Corp. has announced a private offering of $500 million in senior notes maturing in 2034. The proceeds will be used to redeem $400 million of existing senior notes due 2028 and repay $100 million of its revolving credit facility. The offering is targeted at qualified institutional buyers and is subject to market conditions.
Read more →-EHC
May 11, 2026Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Post Falls, Idaho
Encompass Health Corp. plans to construct a 50-bed inpatient rehabilitation hospital in Post Falls, Idaho, aimed at serving patients recovering from serious illnesses and injuries. The facility will offer specialized therapies and advanced rehabilitation technology. Expected to open in 2028, it will expand the company's presence in Idaho, addressing the growing need for rehabilitation services in the region.
Read more →About Encompass Health Corporation
Headquarters9001 LIBERTY PARKWAY, BIRMINGHAM, AL, 35242
BIOPHARMAWATCH ELITE PLUS
Trade the next EHC catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime